Trial intelligence / Profile preview

Pharmacological Treatment in Osteoarthritis (hand osteoarthritis)

2010-019684-11Phase 3Active

Sponsor
Maasstad Ziekenhuis
Start
May 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of hydroxychloroquine in osteoarthritis (OA), sponsored by Maasstad Ziekenhuis. Primary endpoint: Pain intensity at week 24. Started May 2010; status: active.

02

Drugs

hydroxychloroquine
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on 2010-019684-11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-019684-11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call